None listed
Conditions
Brief summary
The Impact of Intermittent fasting has been recommended in several types of disorders in order to increase and improve the liver function. However, there are no studies to support its effectiveness. Therefore, through the Doppler ultrasound, we inten to evaluate the effect of Impact of Intermittent fasting on changes in LDL cholesterol and glucose in patients with liver fibrosis. The conceptual hypothesis of our study will be that "the Intermittent fasting improves LDL cholesterol and glucose," so that Intermittent fasting may change the function of the viscera itself.
Interventions
The subjects will perform intermittent fasting during 3 months . Participants will consume no food or drinks asides from the exceptions listed between 20:00 and 13:00 the following day, three days per week for three months.
They could drink some Infusions, water or coffee during the period of voluntary fasting. They can not combine with milk, sweeteners like sugar, saccharin or derivatives.
Participants will fill in a table with their food diary
We´ll do a blood test before the procedure (mont
The subjects will perform intermittent fasting during 3 months . Participants will consume no food or drinks asides from the exceptions listed between 20:00 and 13:00 the following day, three days per week for three months. They could drink some Infusions, water or coffee during the period of voluntary fasting. They can not combine with milk, sweeteners like sugar, saccharin or derivatives. Participants will fill in a table with their food diary We´ll do a blood test before the procedure (month 0), during (2 months) and the end of the study (3 months).
Sponsors
Camilo Jose Cela University
Study design
Allocation
Randomised controlled trial
Primary purpose
Treatment
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Inclusion criteria will be subjects of both sexes who have hepatic fibrosis, aged between 18 and 65 years, must have fasted for at least 8 hours
Exclusion criteria
Subjects presenting the following could not participate in the study (i) pregnant women, (ii) psychotic problems, (iii) primary cancer or current metastases, (iv) current gastrointestinal bleeding, (v) liver transplants ( vi) polycystic liver or hepatobiliary infarction (vii) intraabdominal infection or inflammation in acute phase, (viii) decompensated heart failure (ix) subjects who are receiving chemotherapy and / or radiotherapy
Outcome results
None listed